As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. You can also read Sandoz CEO Richard Saynor on what the 2024 conversation is missing.
The future of health care starts on Jan. 20, 2025. The stakes for Americans could not be higher.
Whether it’s Vice President Kamala Harris or former President Donald Trump in the White House that day, the health care industry must not lose sight of what matters most: giving all Americans more affordable access to the most innovative medicines.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
